Search for Companies, Tipsters or Sources…
Companies
Tipsters
Brokers
Sources
Or view the latest share tips
Company Results
Tipster results
Broker results
Sources results
Fund Manager results
Tips from these results
Recent Share tips:
- Buy Dowlais Group (DWL) by Jefferies
- Buy Norcros (NXR) by Berenberg
- Buy Volex (VLX) by Tom Winnifrith in ShareProphets
- Buy Volex (VLX) by Steve Moore in ShareProphets
- Buy Origin Enterprises (CDI) (OGN) by Shore Capital
- Buy Victorian Plumbing Group (VIC) by Shore Capital
- Avoid Cropper (James) (CRPR) by Steve Moore in ShareProphets
- Buy Close Brothers Group (CBG) by Shore Capital
- Buy WH Smith (SMWH) by Canaccord Genuity
- Hold Halma (HLMA) by Shore Capital
- Buy Speedy Hire (SDY) by Canaccord Genuity
- Buy Norcros (NXR) by Shore Capital
- Buy XPS Pensions Group (XPS) by Canaccord Genuity
- Hold CMC Markets (CMCX) by Shore Capital
- Hold Warehouse Reit (WHR) by Shore Capital
- Buy Jet2 (JET2) by Canaccord Genuity
- Underperform Halma (HLMA) by Jefferies
- Avoid Churchill China (CHH) by Steve Moore in ShareProphets
- Buy Sage Group (SGE) by Bank of America
- Hold JD Sports Fashion (JD.) by Harvey Jones in The Motley Fool
Oncimmune Holdings (ONC) Share Price
Health Care Sector
NOTE: This is based on 7 open tips for Oncimmune Holdings (ONC)
| Latest Bid : 15.00p | Latest Ask : 15.40p |
| High Today : 15.23p | Low Today : 15.10p |
| This Years High : 29.10p | This Years Low : 9.57p |
| Volume : 91,185 | MKT Cap : £17.09M |
| Trading Velocity : Premium Only | Activity Score : Premium Only |
| Consensus Score : Premium Only | Momentum Score : Premium Only |
Oncimmune Holdings (ONC) Overview
We are leaders in immune biomarkers; our vision is to enable personalised, data-driven clinical decisions across the cancer care continuum. Using our unique expertise and proprietary technology we aim to transform the way disease is diagnosed and treated around the world. We know that detecting the disease early can improve the ability to treat cancer and enhance chances of survival.Oncimmune Holdings (ONC) Latest Tips
| Type | Tipster | SectorScore | Start date | Performance |
|---|---|---|---|---|
| Risky Buy | Kirsteen Mackay | Premium Only | 2020-10-13 18:00:00 13/10/2020 | -91.48% |
| Corporate | FinnCap | Premium Only | 2020-03-18 08:55:00 18/03/2020 | – |
| Corporate | FinnCap | Premium Only | 2020-03-04 11:00:00 04/03/2020 | – |
| Corporate | FinnCap | Premium Only | 2020-02-12 09:50:00 12/02/2020 | – |
| Corporate | FinnCap | Premium Only | 2019-11-22 10:25:00 22/11/2019 | – |
Oncimmune Holdings (ONC) Active Short Positions
| Fund Manager | Position | Date | ||
|---|---|---|---|---|
| No active short positions | ||||
| Latest Bid : 15.00p | Latest Ask : 15.40p |
| High Today : 15.23p | Low Today : 15.10p |
| This Years High : 29.10p | This Years Low : 9.57p |
| Volume : 91,185 | MKT Cap : £17.09M |
Oncimmune Holdings Overview
We are leaders in immune biomarkers; our vision is to enable personalised, data-driven clinical decisions across the cancer care continuum. Using our unique expertise and proprietary technology we aim to transform the way disease is diagnosed and treated around the world. We know that detecting the disease early can improve the ability to treat cancer and enhance chances of survival.NOTE: This description is in part generated by ChatGPT and not an endorsement by or the opinion of Stockomendation Ltd.
Latest Oncimmune Holdings Tips
| Type | Tipster | SectorScore | Start date | Performance |
|---|---|---|---|---|
| Risky Buy | Kirsteen Mackay | Premium Only | 2020-10-13 18:00:00 13/10/2020 | -91.48% |
| Corporate | FinnCap | Premium Only | 2020-03-18 08:55:00 18/03/2020 | – |
| Corporate | FinnCap | Premium Only | 2020-03-04 11:00:00 04/03/2020 | – |
| Corporate | FinnCap | Premium Only | 2020-02-12 09:50:00 12/02/2020 | – |
| Corporate | FinnCap | Premium Only | 2019-11-22 10:25:00 22/11/2019 | – |